Campbell & Co Investment Adviser’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-324,585
Closed -$1.06M 1164
2024
Q2
$1.06M Buy
+324,585
New +$1.06M 0.09% 340
2023
Q2
Sell
-59,651
Closed -$340K 961
2023
Q1
$340K Buy
59,651
+9,929
+20% +$56.6K 0.06% 564
2022
Q4
$502K Buy
49,722
+35,290
+245% +$356K 0.12% 313
2022
Q3
$323K Buy
+14,432
New +$323K 0.07% 457